First-of-its-kind cancer drug effective in 93% of pediatric patients

[News]

A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.

More... (https://www.news-medical.net/news/20180330/First-of-its-kind-cancer-drug-effective-in-9325-of-pediatric-patients.aspx)